Leukemia clinical trials in Vermont
4 studies for Leukemia are looking for participants at sites in Vermont.
Cities in Vermont
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- University of Vermont, Burlington
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- University of Vermont Medical Center, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07007312Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- University of Vermont Medical Center, Burlington
RecruitingObservational study
Up to age 30 · All sexes · Updated Jul 16, 2026 · NCT04968834Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- University of Vermont and State Agricultural College, Burlington
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.